Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...